FOSAPREPITANT DIMEGLUMINE vs FOSPHENYTOIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSAPREPITANT DIMEGLUMINE vs FOSPHENYTOIN: Safety Overview
| Metric | FOSAPREPITANT DIMEGLUMINE | FOSPHENYTOIN |
|---|---|---|
| Total FAERS Reports | 888 | 1,378 |
| Deaths Reported | 118 | 166 |
| Death Rate | 13.3% | 12.0% |
| Hospitalizations | 364 | 646 |
| Average Patient Age | 57.0 yrs | 37.5 yrs |
| % Female Patients | 50.1% | 52.4% |
| FDA Approval Date | Aug 20, 2020 | Aug 5, 1996 |
| Manufacturer | Dr. Reddy's Laboratories Inc., | Pfizer Laboratories Div Pfizer Inc |
| Route | INTRAVENOUS | INTRAMUSCULAR |
| Marketing Status | Discontinued | Prescription |